Feeds › Merger clearances (HSR)
Merger clearances (HSR)
Mergers and acquisitions the FTC and Justice Department cleared early under the Hart-Scott-Rodino Act, with the public companies among them. Granted requests only.
About this data
- What it is
- Companies planning a merger or acquisition above a size threshold must tell the FTC and the Justice Department first and wait 30 days before closing (the Hart-Scott-Rodino Act). The parties can ask for that wait to end early, and when the agencies agree, the FTC publishes an early termination notice. This feed lists those notices: the buyer, the target, the entities being acquired and the day early termination was granted. We match each name to a public company when it lines up.
- Who files it
- The FTC, which publishes a notice once it and the Department of Justice have granted the request.
- How current
- We check the FTC's list every day. A notice is published when early termination is granted, which is before the deal closes.
- Terms
- Hart-Scott-RodinoThe Hart-Scott-Rodino Act requires companies planning a merger or acquisition above a size threshold to tell the FTC and the Justice Department first and wait 30 days before closing, so the agencies can look for competition problems.Early terminationThe parties can ask for that waiting period to end sooner. When the agencies agree, the FTC publishes an early termination notice. It means the deal was cleared to close early, not that the agencies endorse it.Possible matchWe match each name to a public company automatically. A name that matches closely is shown as a company; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly. Most parties are private companies and funds and have no match.
- Worth knowing
- This is a partial list of deals, not every merger. Only requests that were granted appear: deals that waited out the full 30 days, deals whose request was refused and deals that were never reportable are not listed. The FTC granted no early terminations from February 2021 until the new HSR form took effect in February 2025, so there is nothing between those dates. A notice does not mean the agencies endorse a deal, and it does not say whether the deal closed. Most buyers and targets are private companies, funds or people. We match names to public companies automatically; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly.
This comes from the FTC's list of early-termination notices.
Source and freshness · Information, not investment advice (disclaimer).
Early terminations granted per month, last 24 months
Only granted requests are listed, not every deal. The FTC granted none from February 2021 until the new HSR form took effect in February 2025.
Latest early terminations granted
Showing: ticker LLY
Only early terminations that were granted are listed, not every deal, and none were granted between February 2021 and February 2025.
| Granted | BuyerThe "acquiring person" in the filing: the ultimate parent entity of the buyer, which can be a company, a fund or a person. We match each name to a public company automatically. A name that matches closely is shown as a company; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly. Most parties are private companies and funds and have no match. | TargetThe "acquired person": the ultimate parent entity of the target. The entities actually being acquired are listed under it. | Transaction | Source |
|---|---|---|---|---|
| Aug 4, 2026 | Eli Lilly and Company | Oura Inc. | 20261885 | FTC ↗ |
| Jun 3, 2026 | Eli Lilly and Company | Ajax Therapeutics, Inc. | 20261394 | FTC ↗ |
| Apr 2, 2026 | Eli Lilly and Company | CSL Limited CSL Behring L.L.C. | 20261058 | FTC ↗ |
| Mar 26, 2026 | Eli Lilly and Company | InSilico Medicine Cayman TopCo Insilico Medicine IP Limited; Insilico Medicine Ltd. and 2 more | 20261000 | FTC ↗ |
| Mar 23, 2026 | Eli Lilly and Company | Innovent Biologics, Inc. Innovent Biologics (SuZhou) Co., Ltd.; Fortvita Biologics Inc. and 2 more | 20260933 | FTC ↗ |
| Feb 11, 2026 | Eli Lilly and Company | Ventyx Biosciences, Inc. | 20260767 | FTC ↗ |
| Dec 19, 2025 | Eli Lilly and Company | ABL Bio Inc. | 20260440 | FTC ↗ |
| Jul 22, 2025 | Eli Lilly and Company | Verve Therapeutics, Inc. | 20251408 | FTC ↗ |
| May 29, 2018 | Eli Lilly and Company | ARMO BioSciences, Inc. | 20181309 | FTC ↗ |
| Aug 23, 2017 | Eli Lilly and Company | Nektar Therapeutics | 20171767 | FTC ↗ |
| May 13, 2015 | Eli Lilly and Company | Bristol-Myers Squibb Company | 20150934 | FTC ↗ |
| Apr 16, 2015 | Eli Lilly and Company | Hanmi Pharmaceutical Co., Ltd. ANIP possible match | 20150816 | FTC ↗ |
| Dec 19, 2014 | Eli Lilly and Company | Novartis AG | 20140956 | FTC ↗ |
| Mar 25, 2014 | Eli Lilly and Company | Paul Wesjohann & Co. GmbH III Lohmann SE | 20140636 | FTC ↗ |
| Feb 7, 2012 | Eli Lilly & Company | Bernhard & Christie Treidl ChemGen Corp. | 20120480 | FTC ↗ |
| Jul 14, 2010 | Eli Lilly and Company | Alnara Pharmaceuticals, Inc. | 20100873 | FTC ↗ |
| Dec 15, 2008 | Eli Lilly and Company | United Therapeutics Corporation | 20090154 | FTC ↗ |
| Sep 16, 2008 | Eli Lilly and Company | Monsanto Company | 20081695 | FTC ↗ |
| Aug 25, 2008 | Covance Inc. | Eli Lilly and Company | 20081629 | FTC ↗ |
| Jan 18, 2008 | Eli Lilly and Company | BioMS Medical Corp. | 20080564 | FTC ↗ |
| Mar 23, 2007 | Eli Lilly and Company | Hypnion, Inc. | 20070890 | FTC ↗ |
| Jan 27, 2005 | Eli Lilly and Company | AstraZeneca Plc IPR Pharmaceuticals, Inc. | 20050466 | FTC ↗ |
| Nov 4, 2004 | ViroPharma Incorporated | Eli Lilly and Company | 20050087 | FTC ↗ |
| Jan 12, 2004 | Eli Lilly and Company | Applied Molecular Evolution, Inc. | 20040293 | FTC ↗ |
| Mar 11, 2002 | aaiPharma Inc. | Eli Lilly and Company | 20020486 | FTC ↗ |
| Oct 29, 2001 | InterMune, Inc. | Eli Lilly and Company | 20020046 | FTC ↗ |
| Sep 19, 2001 | Eli Lilly and Company | Jeanne-Marie Lecomte Bioprojet, Societe Civile de Recherche | 20012396 | FTC ↗ |
| Aug 24, 2001 | Eli Lilly and Company | Isis Pharmaceuticals, Inc. IONS possible match | 20012329 | FTC ↗ |
| Aug 24, 2001 | Eli Lilly and Company | Isis Pharmaceuticals, Inc. IONS possible match | 20012330 | FTC ↗ |
| Sep 29, 2000 | H Group Holding, Inc. | Eli Lilly and Company | 20005085 | FTC ↗ |
| Aug 16, 1999 | King Pharmaceuticals, Inc. | Eli Lilly and Company | 19994034 | FTC ↗ |
31 items, most recent first (up to 50). Each row links to the FTC page that lists the notices; the transaction number identifies it there. Updated Nov 15, 2026, 4:55 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances